Global Nicotinamide Mononucleotide (NMN) Market Growth 2026-2032
The global Nicotinamide Mononucleotide (NMN) market size is predicted to grow from US$ 186 million in 2025 to US$ 381 million in 2032; it is expected to grow at a CAGR of 9.5% from 2026 to 2032.
In 2025, global sales volume of Nicotinamide Mononucleotide (NMN) reached 397.8 metric tons, with an average price of $478 per kilogram.
Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
NMN is a precursor of nicotinamide adenine dinucleotide (NAD+), which plays a vital role in cell metabolism and energy production. As we age, the level of NAD+ in the human body gradually decreases, resulting in weakened cell metabolism, which in turn triggers a series of aging-related diseases. Therefore, increasing the level of NAD+ in the body by supplementing NMN has become a new way to fight aging and maintain good health.
With the general improvement of global health awareness and continuous breakthroughs in scientific research and technology, the growth momentum of the NMN market will continue to increase. In the future, the NMN market will achieve a deeper cross-border integration with other health industries such as biotechnology, precision medicine, and nutritional supplements, giving rise to a series of innovative products and service models to meet consumers' more personalized and precise health needs.
At present, nicotinamide mononucleotide (NMN) is still in the development stage. There are not many manufacturers in the global market, and consumers have weak awareness of its use, especially in developing countries. The demand is lower than that in developed countries around the world, but the demand in developing countries is growing rapidly. Leading giants have proposed expansion plans and increased production bases.
Nicotinamide mononucleotide (NMN) core manufacturers include GeneHarbor, Mirailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production area, accounting for about 84% of the global market share, followed by North America and Japan. The downstream applications of nicotinamide mononucleotide include health products, cosmetics, etc. Globally, health products are the largest application market, and raw materials for health products account for 82% of the total sales of nicotinamide mononucleotide in 2025.
This Insight Report provides a comprehensive analysis of the global Nicotinamide Mononucleotide (NMN) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nicotinamide Mononucleotide (NMN) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nicotinamide Mononucleotide (NMN) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nicotinamide Mononucleotide (NMN) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nicotinamide Mononucleotide (NMN).
This report presents a comprehensive overview, market shares, and growth opportunities of Nicotinamide Mononucleotide (NMN) market by product type, application, key manufacturers and key regions and countries.
In 2025, global sales volume of Nicotinamide Mononucleotide (NMN) reached 397.8 metric tons, with an average price of $478 per kilogram.
Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
NMN is a precursor of nicotinamide adenine dinucleotide (NAD+), which plays a vital role in cell metabolism and energy production. As we age, the level of NAD+ in the human body gradually decreases, resulting in weakened cell metabolism, which in turn triggers a series of aging-related diseases. Therefore, increasing the level of NAD+ in the body by supplementing NMN has become a new way to fight aging and maintain good health.
With the general improvement of global health awareness and continuous breakthroughs in scientific research and technology, the growth momentum of the NMN market will continue to increase. In the future, the NMN market will achieve a deeper cross-border integration with other health industries such as biotechnology, precision medicine, and nutritional supplements, giving rise to a series of innovative products and service models to meet consumers' more personalized and precise health needs.
At present, nicotinamide mononucleotide (NMN) is still in the development stage. There are not many manufacturers in the global market, and consumers have weak awareness of its use, especially in developing countries. The demand is lower than that in developed countries around the world, but the demand in developing countries is growing rapidly. Leading giants have proposed expansion plans and increased production bases.
Nicotinamide mononucleotide (NMN) core manufacturers include GeneHarbor, Mirailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production area, accounting for about 84% of the global market share, followed by North America and Japan. The downstream applications of nicotinamide mononucleotide include health products, cosmetics, etc. Globally, health products are the largest application market, and raw materials for health products account for 82% of the total sales of nicotinamide mononucleotide in 2025.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Nicotinamide Mononucleotide (NMN) Industry Forecast” looks at past sales and reviews total world Nicotinamide Mononucleotide (NMN) sales in 2025, providing a comprehensive analysis by region and market sector of projected Nicotinamide Mononucleotide (NMN) sales for 2026 through 2032. With Nicotinamide Mononucleotide (NMN) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nicotinamide Mononucleotide (NMN) industry.This Insight Report provides a comprehensive analysis of the global Nicotinamide Mononucleotide (NMN) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nicotinamide Mononucleotide (NMN) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nicotinamide Mononucleotide (NMN) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nicotinamide Mononucleotide (NMN) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nicotinamide Mononucleotide (NMN).
This report presents a comprehensive overview, market shares, and growth opportunities of Nicotinamide Mononucleotide (NMN) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Content ?98%
- Content ?98%
Segmentation by Production Process:
- Enzymatic Catalysis
- Microbial Fermentation
- Chemical Synthesis
- Other
Segmentation by Grade:
- Food Grade
- Cosmetic Grade
- Pharmaceutical Grade
Segmentation by Application:
- Health Care Products
- Cosmetics
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GeneHarbor (HK)
- Herbalmax (US)
- Genex Formulas (US)
- Mirailab Bioscience (JP)
- Maac10 Formulas (US)
- EffePharm (CN)
- Bontac (CN)
- CELFULL (US)
- Kingdomway (CN)
- ABA Chemical (CN)
- SyncoZymes (CN)
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Nicotinamide Mononucleotide (NMN) market?
- What factors are driving Nicotinamide Mononucleotide (NMN) market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Nicotinamide Mononucleotide (NMN) market opportunities vary by end market size?
- How does Nicotinamide Mononucleotide (NMN) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nicotinamide Mononucleotide (NMN) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Nicotinamide Mononucleotide (NMN) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Nicotinamide Mononucleotide (NMN) by Country/Region, 2021, 2025 & 2032
2.2 Nicotinamide Mononucleotide (NMN) Segment by Type
2.2.1 Content ?98%
2.2.2 Content ?98%
2.2.3 Nicotinamide Mononucleotide (NMN) Sales by Type
2.2.3.1 Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Nicotinamide Mononucleotide (NMN) Sale Price by Type (2021-2026)
2.3 Nicotinamide Mononucleotide (NMN) Segment by Production Process
2.3.1 Enzymatic Catalysis
2.3.2 Microbial Fermentation
2.3.3 Chemical Synthesis
2.3.4 Other
2.3.5 Nicotinamide Mononucleotide (NMN) Sales by Production Process
2.3.5.1 Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Production Process (2021-2026)
2.3.5.2 Global Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Production Process (2021-2026)
2.3.5.3 Global Nicotinamide Mononucleotide (NMN) Sale Price by Production Process (2021-2026)
2.4 Nicotinamide Mononucleotide (NMN) Segment by Grade
2.4.1 Food Grade
2.4.2 Cosmetic Grade
2.4.3 Pharmaceutical Grade
2.4.4 Nicotinamide Mononucleotide (NMN) Sales by Grade
2.4.4.1 Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Grade (2021-2026)
2.4.4.2 Global Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Grade (2021-2026)
2.4.4.3 Global Nicotinamide Mononucleotide (NMN) Sale Price by Grade (2021-2026)
2.5 Nicotinamide Mononucleotide (NMN) Segment by Application
2.5.1 Health Care Products
2.5.2 Cosmetics
2.5.3 Others
2.5.4 Nicotinamide Mononucleotide (NMN) Sales by Application
2.5.4.1 Global Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2021-2026)
2.5.4.2 Global Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Nicotinamide Mononucleotide (NMN) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Nicotinamide Mononucleotide (NMN) Breakdown Data by Company
3.1.1 Global Nicotinamide Mononucleotide (NMN) Annual Sales by Company (2021-2026)
3.1.2 Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Company (2021-2026)
3.2 Global Nicotinamide Mononucleotide (NMN) Annual Revenue by Company (2021-2026)
3.2.1 Global Nicotinamide Mononucleotide (NMN) Revenue by Company (2021-2026)
3.2.2 Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2021-2026)
3.3 Global Nicotinamide Mononucleotide (NMN) Sale Price by Company
3.4 Key Manufacturers Nicotinamide Mononucleotide (NMN) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nicotinamide Mononucleotide (NMN) Product Location Distribution
3.4.2 Players Nicotinamide Mononucleotide (NMN) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NICOTINAMIDE MONONUCLEOTIDE (NMN) BY GEOGRAPHIC REGION
4.1 World Historic Nicotinamide Mononucleotide (NMN) Market Size by Geographic Region (2021-2026)
4.1.1 Global Nicotinamide Mononucleotide (NMN) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Nicotinamide Mononucleotide (NMN) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Nicotinamide Mononucleotide (NMN) Market Size by Country/Region (2021-2026)
4.2.1 Global Nicotinamide Mononucleotide (NMN) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Nicotinamide Mononucleotide (NMN) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nicotinamide Mononucleotide (NMN) Sales Growth
4.4 APAC Nicotinamide Mononucleotide (NMN) Sales Growth
4.5 Europe Nicotinamide Mononucleotide (NMN) Sales Growth
4.6 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Growth
5 AMERICAS
5.1 Americas Nicotinamide Mononucleotide (NMN) Sales by Country
5.1.1 Americas Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026)
5.1.2 Americas Nicotinamide Mononucleotide (NMN) Revenue by Country (2021-2026)
5.2 Americas Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026)
5.3 Americas Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nicotinamide Mononucleotide (NMN) Sales by Region
6.1.1 APAC Nicotinamide Mononucleotide (NMN) Sales by Region (2021-2026)
6.1.2 APAC Nicotinamide Mononucleotide (NMN) Revenue by Region (2021-2026)
6.2 APAC Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026)
6.3 APAC Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nicotinamide Mononucleotide (NMN) by Country
7.1.1 Europe Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026)
7.1.2 Europe Nicotinamide Mononucleotide (NMN) Revenue by Country (2021-2026)
7.2 Europe Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026)
7.3 Europe Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) by Country
8.1.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue by Country (2021-2026)
8.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026)
8.3 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nicotinamide Mononucleotide (NMN)
10.3 Manufacturing Process Analysis of Nicotinamide Mononucleotide (NMN)
10.4 Industry Chain Structure of Nicotinamide Mononucleotide (NMN)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nicotinamide Mononucleotide (NMN) Distributors
11.3 Nicotinamide Mononucleotide (NMN) Customer
12 WORLD FORECAST REVIEW FOR NICOTINAMIDE MONONUCLEOTIDE (NMN) BY GEOGRAPHIC REGION
12.1 Global Nicotinamide Mononucleotide (NMN) Market Size Forecast by Region
12.1.1 Global Nicotinamide Mononucleotide (NMN) Forecast by Region (2027-2032)
12.1.2 Global Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Nicotinamide Mononucleotide (NMN) Forecast by Type (2027-2032)
12.7 Global Nicotinamide Mononucleotide (NMN) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GeneHarbor (HK)
13.1.1 GeneHarbor (HK) Company Information
13.1.2 GeneHarbor (HK) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.1.3 GeneHarbor (HK) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GeneHarbor (HK) Main Business Overview
13.1.5 GeneHarbor (HK) Latest Developments
13.2 Herbalmax (US)
13.2.1 Herbalmax (US) Company Information
13.2.2 Herbalmax (US) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.2.3 Herbalmax (US) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Herbalmax (US) Main Business Overview
13.2.5 Herbalmax (US) Latest Developments
13.3 Genex Formulas (US)
13.3.1 Genex Formulas (US) Company Information
13.3.2 Genex Formulas (US) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.3.3 Genex Formulas (US) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Genex Formulas (US) Main Business Overview
13.3.5 Genex Formulas (US) Latest Developments
13.4 Mirailab Bioscience (JP)
13.4.1 Mirailab Bioscience (JP) Company Information
13.4.2 Mirailab Bioscience (JP) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.4.3 Mirailab Bioscience (JP) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Mirailab Bioscience (JP) Main Business Overview
13.4.5 Mirailab Bioscience (JP) Latest Developments
13.5 Maac10 Formulas (US)
13.5.1 Maac10 Formulas (US) Company Information
13.5.2 Maac10 Formulas (US) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.5.3 Maac10 Formulas (US) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Maac10 Formulas (US) Main Business Overview
13.5.5 Maac10 Formulas (US) Latest Developments
13.6 EffePharm (CN)
13.6.1 EffePharm (CN) Company Information
13.6.2 EffePharm (CN) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.6.3 EffePharm (CN) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 EffePharm (CN) Main Business Overview
13.6.5 EffePharm (CN) Latest Developments
13.7 Bontac (CN)
13.7.1 Bontac (CN) Company Information
13.7.2 Bontac (CN) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.7.3 Bontac (CN) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Bontac (CN) Main Business Overview
13.7.5 Bontac (CN) Latest Developments
13.8 CELFULL (US)
13.8.1 CELFULL (US) Company Information
13.8.2 CELFULL (US) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.8.3 CELFULL (US) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 CELFULL (US) Main Business Overview
13.8.5 CELFULL (US) Latest Developments
13.9 Kingdomway (CN)
13.9.1 Kingdomway (CN) Company Information
13.9.2 Kingdomway (CN) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.9.3 Kingdomway (CN) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Kingdomway (CN) Main Business Overview
13.9.5 Kingdomway (CN) Latest Developments
13.10 ABA Chemical (CN)
13.10.1 ABA Chemical (CN) Company Information
13.10.2 ABA Chemical (CN) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.10.3 ABA Chemical (CN) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 ABA Chemical (CN) Main Business Overview
13.10.5 ABA Chemical (CN) Latest Developments
13.11 SyncoZymes (CN)
13.11.1 SyncoZymes (CN) Company Information
13.11.2 SyncoZymes (CN) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.11.3 SyncoZymes (CN) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 SyncoZymes (CN) Main Business Overview
13.11.5 SyncoZymes (CN) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nicotinamide Mononucleotide (NMN) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Nicotinamide Mononucleotide (NMN) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Nicotinamide Mononucleotide (NMN) by Country/Region, 2021, 2025 & 2032
2.2 Nicotinamide Mononucleotide (NMN) Segment by Type
2.2.1 Content ?98%
2.2.2 Content ?98%
2.2.3 Nicotinamide Mononucleotide (NMN) Sales by Type
2.2.3.1 Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Nicotinamide Mononucleotide (NMN) Sale Price by Type (2021-2026)
2.3 Nicotinamide Mononucleotide (NMN) Segment by Production Process
2.3.1 Enzymatic Catalysis
2.3.2 Microbial Fermentation
2.3.3 Chemical Synthesis
2.3.4 Other
2.3.5 Nicotinamide Mononucleotide (NMN) Sales by Production Process
2.3.5.1 Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Production Process (2021-2026)
2.3.5.2 Global Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Production Process (2021-2026)
2.3.5.3 Global Nicotinamide Mononucleotide (NMN) Sale Price by Production Process (2021-2026)
2.4 Nicotinamide Mononucleotide (NMN) Segment by Grade
2.4.1 Food Grade
2.4.2 Cosmetic Grade
2.4.3 Pharmaceutical Grade
2.4.4 Nicotinamide Mononucleotide (NMN) Sales by Grade
2.4.4.1 Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Grade (2021-2026)
2.4.4.2 Global Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Grade (2021-2026)
2.4.4.3 Global Nicotinamide Mononucleotide (NMN) Sale Price by Grade (2021-2026)
2.5 Nicotinamide Mononucleotide (NMN) Segment by Application
2.5.1 Health Care Products
2.5.2 Cosmetics
2.5.3 Others
2.5.4 Nicotinamide Mononucleotide (NMN) Sales by Application
2.5.4.1 Global Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2021-2026)
2.5.4.2 Global Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Nicotinamide Mononucleotide (NMN) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Nicotinamide Mononucleotide (NMN) Breakdown Data by Company
3.1.1 Global Nicotinamide Mononucleotide (NMN) Annual Sales by Company (2021-2026)
3.1.2 Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Company (2021-2026)
3.2 Global Nicotinamide Mononucleotide (NMN) Annual Revenue by Company (2021-2026)
3.2.1 Global Nicotinamide Mononucleotide (NMN) Revenue by Company (2021-2026)
3.2.2 Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2021-2026)
3.3 Global Nicotinamide Mononucleotide (NMN) Sale Price by Company
3.4 Key Manufacturers Nicotinamide Mononucleotide (NMN) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nicotinamide Mononucleotide (NMN) Product Location Distribution
3.4.2 Players Nicotinamide Mononucleotide (NMN) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NICOTINAMIDE MONONUCLEOTIDE (NMN) BY GEOGRAPHIC REGION
4.1 World Historic Nicotinamide Mononucleotide (NMN) Market Size by Geographic Region (2021-2026)
4.1.1 Global Nicotinamide Mononucleotide (NMN) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Nicotinamide Mononucleotide (NMN) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Nicotinamide Mononucleotide (NMN) Market Size by Country/Region (2021-2026)
4.2.1 Global Nicotinamide Mononucleotide (NMN) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Nicotinamide Mononucleotide (NMN) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nicotinamide Mononucleotide (NMN) Sales Growth
4.4 APAC Nicotinamide Mononucleotide (NMN) Sales Growth
4.5 Europe Nicotinamide Mononucleotide (NMN) Sales Growth
4.6 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Growth
5 AMERICAS
5.1 Americas Nicotinamide Mononucleotide (NMN) Sales by Country
5.1.1 Americas Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026)
5.1.2 Americas Nicotinamide Mononucleotide (NMN) Revenue by Country (2021-2026)
5.2 Americas Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026)
5.3 Americas Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nicotinamide Mononucleotide (NMN) Sales by Region
6.1.1 APAC Nicotinamide Mononucleotide (NMN) Sales by Region (2021-2026)
6.1.2 APAC Nicotinamide Mononucleotide (NMN) Revenue by Region (2021-2026)
6.2 APAC Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026)
6.3 APAC Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nicotinamide Mononucleotide (NMN) by Country
7.1.1 Europe Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026)
7.1.2 Europe Nicotinamide Mononucleotide (NMN) Revenue by Country (2021-2026)
7.2 Europe Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026)
7.3 Europe Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) by Country
8.1.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue by Country (2021-2026)
8.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026)
8.3 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nicotinamide Mononucleotide (NMN)
10.3 Manufacturing Process Analysis of Nicotinamide Mononucleotide (NMN)
10.4 Industry Chain Structure of Nicotinamide Mononucleotide (NMN)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nicotinamide Mononucleotide (NMN) Distributors
11.3 Nicotinamide Mononucleotide (NMN) Customer
12 WORLD FORECAST REVIEW FOR NICOTINAMIDE MONONUCLEOTIDE (NMN) BY GEOGRAPHIC REGION
12.1 Global Nicotinamide Mononucleotide (NMN) Market Size Forecast by Region
12.1.1 Global Nicotinamide Mononucleotide (NMN) Forecast by Region (2027-2032)
12.1.2 Global Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Nicotinamide Mononucleotide (NMN) Forecast by Type (2027-2032)
12.7 Global Nicotinamide Mononucleotide (NMN) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GeneHarbor (HK)
13.1.1 GeneHarbor (HK) Company Information
13.1.2 GeneHarbor (HK) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.1.3 GeneHarbor (HK) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GeneHarbor (HK) Main Business Overview
13.1.5 GeneHarbor (HK) Latest Developments
13.2 Herbalmax (US)
13.2.1 Herbalmax (US) Company Information
13.2.2 Herbalmax (US) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.2.3 Herbalmax (US) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Herbalmax (US) Main Business Overview
13.2.5 Herbalmax (US) Latest Developments
13.3 Genex Formulas (US)
13.3.1 Genex Formulas (US) Company Information
13.3.2 Genex Formulas (US) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.3.3 Genex Formulas (US) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Genex Formulas (US) Main Business Overview
13.3.5 Genex Formulas (US) Latest Developments
13.4 Mirailab Bioscience (JP)
13.4.1 Mirailab Bioscience (JP) Company Information
13.4.2 Mirailab Bioscience (JP) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.4.3 Mirailab Bioscience (JP) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Mirailab Bioscience (JP) Main Business Overview
13.4.5 Mirailab Bioscience (JP) Latest Developments
13.5 Maac10 Formulas (US)
13.5.1 Maac10 Formulas (US) Company Information
13.5.2 Maac10 Formulas (US) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.5.3 Maac10 Formulas (US) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Maac10 Formulas (US) Main Business Overview
13.5.5 Maac10 Formulas (US) Latest Developments
13.6 EffePharm (CN)
13.6.1 EffePharm (CN) Company Information
13.6.2 EffePharm (CN) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.6.3 EffePharm (CN) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 EffePharm (CN) Main Business Overview
13.6.5 EffePharm (CN) Latest Developments
13.7 Bontac (CN)
13.7.1 Bontac (CN) Company Information
13.7.2 Bontac (CN) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.7.3 Bontac (CN) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Bontac (CN) Main Business Overview
13.7.5 Bontac (CN) Latest Developments
13.8 CELFULL (US)
13.8.1 CELFULL (US) Company Information
13.8.2 CELFULL (US) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.8.3 CELFULL (US) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 CELFULL (US) Main Business Overview
13.8.5 CELFULL (US) Latest Developments
13.9 Kingdomway (CN)
13.9.1 Kingdomway (CN) Company Information
13.9.2 Kingdomway (CN) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.9.3 Kingdomway (CN) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Kingdomway (CN) Main Business Overview
13.9.5 Kingdomway (CN) Latest Developments
13.10 ABA Chemical (CN)
13.10.1 ABA Chemical (CN) Company Information
13.10.2 ABA Chemical (CN) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.10.3 ABA Chemical (CN) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 ABA Chemical (CN) Main Business Overview
13.10.5 ABA Chemical (CN) Latest Developments
13.11 SyncoZymes (CN)
13.11.1 SyncoZymes (CN) Company Information
13.11.2 SyncoZymes (CN) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.11.3 SyncoZymes (CN) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 SyncoZymes (CN) Main Business Overview
13.11.5 SyncoZymes (CN) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nicotinamide Mononucleotide (NMN) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Nicotinamide Mononucleotide (NMN) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Content ?98%
Table 4. Major Players of Content ?98%
Table 5. Global Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Tons)
Table 6. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2021-2026)
Table 7. Global Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2021-2026)
Table 9. Global Nicotinamide Mononucleotide (NMN) Sale Price by Type (2021-2026) & (US$/Kg)
Table 10. Major Players of Enzymatic Catalysis
Table 11. Major Players of Microbial Fermentation
Table 12. Major Players of Chemical Synthesis
Table 13. Major Players of Other
Table 14. Global Nicotinamide Mononucleotide (NMN) Sales by Production Process (2021-2026) & (Tons)
Table 15. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Production Process (2021-2026)
Table 16. Global Nicotinamide Mononucleotide (NMN) Revenue by Production Process (2021-2026) & ($ million)
Table 17. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Production Process (2021-2026)
Table 18. Global Nicotinamide Mononucleotide (NMN) Sale Price by Production Process (2021-2026) & (US$/Kg)
Table 19. Major Players of Food Grade
Table 20. Major Players of Cosmetic Grade
Table 21. Major Players of Pharmaceutical Grade
Table 22. Global Nicotinamide Mononucleotide (NMN) Sales by Grade (2021-2026) & (Tons)
Table 23. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Grade (2021-2026)
Table 24. Global Nicotinamide Mononucleotide (NMN) Revenue by Grade (2021-2026) & ($ million)
Table 25. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Grade (2021-2026)
Table 26. Global Nicotinamide Mononucleotide (NMN) Sale Price by Grade (2021-2026) & (US$/Kg)
Table 27. Global Nicotinamide Mononucleotide (NMN) Sale by Application (2021-2026) & (Tons)
Table 28. Global Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2021-2026)
Table 29. Global Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & ($ million)
Table 30. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2021-2026)
Table 31. Global Nicotinamide Mononucleotide (NMN) Sale Price by Application (2021-2026) & (US$/Kg)
Table 32. Global Nicotinamide Mononucleotide (NMN) Sales by Company (2021-2026) & (Tons)
Table 33. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Company (2021-2026)
Table 34. Global Nicotinamide Mononucleotide (NMN) Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2021-2026)
Table 36. Global Nicotinamide Mononucleotide (NMN) Sale Price by Company (2021-2026) & (US$/Kg)
Table 37. Key Manufacturers Nicotinamide Mononucleotide (NMN) Producing Area Distribution and Sales Area
Table 38. Players Nicotinamide Mononucleotide (NMN) Products Offered
Table 39. Nicotinamide Mononucleotide (NMN) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Nicotinamide Mononucleotide (NMN) Sales by Geographic Region (2021-2026) & (Tons)
Table 43. Global Nicotinamide Mononucleotide (NMN) Sales Market Share Geographic Region (2021-2026)
Table 44. Global Nicotinamide Mononucleotide (NMN) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Nicotinamide Mononucleotide (NMN) Sales by Country/Region (2021-2026) & (Tons)
Table 47. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2021-2026)
Table 48. Global Nicotinamide Mononucleotide (NMN) Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Tons)
Table 51. Americas Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2021-2026)
Table 52. Americas Nicotinamide Mononucleotide (NMN) Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Tons)
Table 54. Americas Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Tons)
Table 55. APAC Nicotinamide Mononucleotide (NMN) Sales by Region (2021-2026) & (Tons)
Table 56. APAC Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2021-2026)
Table 57. APAC Nicotinamide Mononucleotide (NMN) Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Tons)
Table 59. APAC Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Tons)
Table 60. Europe Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Tons)
Table 61. Europe Nicotinamide Mononucleotide (NMN) Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Tons)
Table 63. Europe Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Tons)
Table 64. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Tons)
Table 65. Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Tons)
Table 67. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Tons)
Table 68. Key Market Drivers & Growth Opportunities of Nicotinamide Mononucleotide (NMN)
Table 69. Key Market Challenges & Risks of Nicotinamide Mononucleotide (NMN)
Table 70. Key Industry Trends of Nicotinamide Mononucleotide (NMN)
Table 71. Nicotinamide Mononucleotide (NMN) Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Nicotinamide Mononucleotide (NMN) Distributors List
Table 74. Nicotinamide Mononucleotide (NMN) Customer List
Table 75. Global Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2027-2032) & (Tons)
Table 76. Global Nicotinamide Mononucleotide (NMN) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2027-2032) & (Tons)
Table 78. Americas Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2027-2032) & (Tons)
Table 80. APAC Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2027-2032) & (Tons)
Table 82. Europe Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2027-2032) & (Tons)
Table 84. Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Nicotinamide Mononucleotide (NMN) Sales Forecast by Type (2027-2032) & (Tons)
Table 86. Global Nicotinamide Mononucleotide (NMN) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Nicotinamide Mononucleotide (NMN) Sales Forecast by Application (2027-2032) & (Tons)
Table 88. Global Nicotinamide Mononucleotide (NMN) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. GeneHarbor (HK) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 90. GeneHarbor (HK) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 91. GeneHarbor (HK) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 92. GeneHarbor (HK) Main Business
Table 93. GeneHarbor (HK) Latest Developments
Table 94. Herbalmax (US) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 95. Herbalmax (US) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 96. Herbalmax (US) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 97. Herbalmax (US) Main Business
Table 98. Herbalmax (US) Latest Developments
Table 99. Genex Formulas (US) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 100. Genex Formulas (US) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 101. Genex Formulas (US) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 102. Genex Formulas (US) Main Business
Table 103. Genex Formulas (US) Latest Developments
Table 104. Mirailab Bioscience (JP) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 105. Mirailab Bioscience (JP) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 106. Mirailab Bioscience (JP) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 107. Mirailab Bioscience (JP) Main Business
Table 108. Mirailab Bioscience (JP) Latest Developments
Table 109. Maac10 Formulas (US) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 110. Maac10 Formulas (US) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 111. Maac10 Formulas (US) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 112. Maac10 Formulas (US) Main Business
Table 113. Maac10 Formulas (US) Latest Developments
Table 114. EffePharm (CN) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 115. EffePharm (CN) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 116. EffePharm (CN) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 117. EffePharm (CN) Main Business
Table 118. EffePharm (CN) Latest Developments
Table 119. Bontac (CN) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 120. Bontac (CN) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 121. Bontac (CN) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 122. Bontac (CN) Main Business
Table 123. Bontac (CN) Latest Developments
Table 124. CELFULL (US) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 125. CELFULL (US) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 126. CELFULL (US) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 127. CELFULL (US) Main Business
Table 128. CELFULL (US) Latest Developments
Table 129. Kingdomway (CN) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 130. Kingdomway (CN) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 131. Kingdomway (CN) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 132. Kingdomway (CN) Main Business
Table 133. Kingdomway (CN) Latest Developments
Table 134. ABA Chemical (CN) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 135. ABA Chemical (CN) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 136. ABA Chemical (CN) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 137. ABA Chemical (CN) Main Business
Table 138. ABA Chemical (CN) Latest Developments
Table 139. SyncoZymes (CN) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 140. SyncoZymes (CN) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 141. SyncoZymes (CN) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 142. SyncoZymes (CN) Main Business
Table 143. SyncoZymes (CN) Latest Developments
Table 1. Nicotinamide Mononucleotide (NMN) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Nicotinamide Mononucleotide (NMN) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Content ?98%
Table 4. Major Players of Content ?98%
Table 5. Global Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Tons)
Table 6. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2021-2026)
Table 7. Global Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2021-2026)
Table 9. Global Nicotinamide Mononucleotide (NMN) Sale Price by Type (2021-2026) & (US$/Kg)
Table 10. Major Players of Enzymatic Catalysis
Table 11. Major Players of Microbial Fermentation
Table 12. Major Players of Chemical Synthesis
Table 13. Major Players of Other
Table 14. Global Nicotinamide Mononucleotide (NMN) Sales by Production Process (2021-2026) & (Tons)
Table 15. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Production Process (2021-2026)
Table 16. Global Nicotinamide Mononucleotide (NMN) Revenue by Production Process (2021-2026) & ($ million)
Table 17. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Production Process (2021-2026)
Table 18. Global Nicotinamide Mononucleotide (NMN) Sale Price by Production Process (2021-2026) & (US$/Kg)
Table 19. Major Players of Food Grade
Table 20. Major Players of Cosmetic Grade
Table 21. Major Players of Pharmaceutical Grade
Table 22. Global Nicotinamide Mononucleotide (NMN) Sales by Grade (2021-2026) & (Tons)
Table 23. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Grade (2021-2026)
Table 24. Global Nicotinamide Mononucleotide (NMN) Revenue by Grade (2021-2026) & ($ million)
Table 25. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Grade (2021-2026)
Table 26. Global Nicotinamide Mononucleotide (NMN) Sale Price by Grade (2021-2026) & (US$/Kg)
Table 27. Global Nicotinamide Mononucleotide (NMN) Sale by Application (2021-2026) & (Tons)
Table 28. Global Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2021-2026)
Table 29. Global Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & ($ million)
Table 30. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2021-2026)
Table 31. Global Nicotinamide Mononucleotide (NMN) Sale Price by Application (2021-2026) & (US$/Kg)
Table 32. Global Nicotinamide Mononucleotide (NMN) Sales by Company (2021-2026) & (Tons)
Table 33. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Company (2021-2026)
Table 34. Global Nicotinamide Mononucleotide (NMN) Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2021-2026)
Table 36. Global Nicotinamide Mononucleotide (NMN) Sale Price by Company (2021-2026) & (US$/Kg)
Table 37. Key Manufacturers Nicotinamide Mononucleotide (NMN) Producing Area Distribution and Sales Area
Table 38. Players Nicotinamide Mononucleotide (NMN) Products Offered
Table 39. Nicotinamide Mononucleotide (NMN) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Nicotinamide Mononucleotide (NMN) Sales by Geographic Region (2021-2026) & (Tons)
Table 43. Global Nicotinamide Mononucleotide (NMN) Sales Market Share Geographic Region (2021-2026)
Table 44. Global Nicotinamide Mononucleotide (NMN) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Nicotinamide Mononucleotide (NMN) Sales by Country/Region (2021-2026) & (Tons)
Table 47. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2021-2026)
Table 48. Global Nicotinamide Mononucleotide (NMN) Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Tons)
Table 51. Americas Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2021-2026)
Table 52. Americas Nicotinamide Mononucleotide (NMN) Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Tons)
Table 54. Americas Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Tons)
Table 55. APAC Nicotinamide Mononucleotide (NMN) Sales by Region (2021-2026) & (Tons)
Table 56. APAC Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2021-2026)
Table 57. APAC Nicotinamide Mononucleotide (NMN) Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Tons)
Table 59. APAC Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Tons)
Table 60. Europe Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Tons)
Table 61. Europe Nicotinamide Mononucleotide (NMN) Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Tons)
Table 63. Europe Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Tons)
Table 64. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Tons)
Table 65. Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Tons)
Table 67. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Tons)
Table 68. Key Market Drivers & Growth Opportunities of Nicotinamide Mononucleotide (NMN)
Table 69. Key Market Challenges & Risks of Nicotinamide Mononucleotide (NMN)
Table 70. Key Industry Trends of Nicotinamide Mononucleotide (NMN)
Table 71. Nicotinamide Mononucleotide (NMN) Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Nicotinamide Mononucleotide (NMN) Distributors List
Table 74. Nicotinamide Mononucleotide (NMN) Customer List
Table 75. Global Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2027-2032) & (Tons)
Table 76. Global Nicotinamide Mononucleotide (NMN) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2027-2032) & (Tons)
Table 78. Americas Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2027-2032) & (Tons)
Table 80. APAC Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2027-2032) & (Tons)
Table 82. Europe Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2027-2032) & (Tons)
Table 84. Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Nicotinamide Mononucleotide (NMN) Sales Forecast by Type (2027-2032) & (Tons)
Table 86. Global Nicotinamide Mononucleotide (NMN) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Nicotinamide Mononucleotide (NMN) Sales Forecast by Application (2027-2032) & (Tons)
Table 88. Global Nicotinamide Mononucleotide (NMN) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. GeneHarbor (HK) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 90. GeneHarbor (HK) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 91. GeneHarbor (HK) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 92. GeneHarbor (HK) Main Business
Table 93. GeneHarbor (HK) Latest Developments
Table 94. Herbalmax (US) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 95. Herbalmax (US) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 96. Herbalmax (US) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 97. Herbalmax (US) Main Business
Table 98. Herbalmax (US) Latest Developments
Table 99. Genex Formulas (US) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 100. Genex Formulas (US) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 101. Genex Formulas (US) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 102. Genex Formulas (US) Main Business
Table 103. Genex Formulas (US) Latest Developments
Table 104. Mirailab Bioscience (JP) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 105. Mirailab Bioscience (JP) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 106. Mirailab Bioscience (JP) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 107. Mirailab Bioscience (JP) Main Business
Table 108. Mirailab Bioscience (JP) Latest Developments
Table 109. Maac10 Formulas (US) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 110. Maac10 Formulas (US) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 111. Maac10 Formulas (US) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 112. Maac10 Formulas (US) Main Business
Table 113. Maac10 Formulas (US) Latest Developments
Table 114. EffePharm (CN) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 115. EffePharm (CN) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 116. EffePharm (CN) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 117. EffePharm (CN) Main Business
Table 118. EffePharm (CN) Latest Developments
Table 119. Bontac (CN) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 120. Bontac (CN) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 121. Bontac (CN) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 122. Bontac (CN) Main Business
Table 123. Bontac (CN) Latest Developments
Table 124. CELFULL (US) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 125. CELFULL (US) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 126. CELFULL (US) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 127. CELFULL (US) Main Business
Table 128. CELFULL (US) Latest Developments
Table 129. Kingdomway (CN) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 130. Kingdomway (CN) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 131. Kingdomway (CN) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 132. Kingdomway (CN) Main Business
Table 133. Kingdomway (CN) Latest Developments
Table 134. ABA Chemical (CN) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 135. ABA Chemical (CN) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 136. ABA Chemical (CN) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 137. ABA Chemical (CN) Main Business
Table 138. ABA Chemical (CN) Latest Developments
Table 139. SyncoZymes (CN) Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 140. SyncoZymes (CN) Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 141. SyncoZymes (CN) Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 142. SyncoZymes (CN) Main Business
Table 143. SyncoZymes (CN) Latest Developments
LIST OF FIGURES
Figure 1. Picture of Nicotinamide Mononucleotide (NMN)
Figure 2. Nicotinamide Mononucleotide (NMN) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nicotinamide Mononucleotide (NMN) Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Nicotinamide Mononucleotide (NMN) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Nicotinamide Mononucleotide (NMN) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2025)
Figure 10. Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Content ?98%
Figure 12. Product Picture of Content ?98%
Figure 13. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Type in 2026
Figure 14. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Enzymatic Catalysis
Figure 16. Product Picture of Microbial Fermentation
Figure 17. Product Picture of Chemical Synthesis
Figure 18. Product Picture of Other
Figure 19. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Production Process in 2026
Figure 20. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Production Process (2021-2026)
Figure 21. Product Picture of Food Grade
Figure 22. Product Picture of Cosmetic Grade
Figure 23. Product Picture of Pharmaceutical Grade
Figure 24. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Grade in 2026
Figure 25. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Grade (2021-2026)
Figure 26. Nicotinamide Mononucleotide (NMN) Consumed in Health Care Products
Figure 27. Global Nicotinamide Mononucleotide (NMN) Market: Health Care Products (2021-2026) & (Tons)
Figure 28. Nicotinamide Mononucleotide (NMN) Consumed in Cosmetics
Figure 29. Global Nicotinamide Mononucleotide (NMN) Market: Cosmetics (2021-2026) & (Tons)
Figure 30. Nicotinamide Mononucleotide (NMN) Consumed in Others
Figure 31. Global Nicotinamide Mononucleotide (NMN) Market: Others (2021-2026) & (Tons)
Figure 32. Global Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2025)
Figure 33. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application in 2025
Figure 34. Nicotinamide Mononucleotide (NMN) Sales by Company in 2025 (Tons)
Figure 35. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Company in 2025
Figure 36. Nicotinamide Mononucleotide (NMN) Revenue by Company in 2025 ($ millions)
Figure 37. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company in 2025
Figure 38. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Nicotinamide Mononucleotide (NMN) Sales 2021-2026 (Tons)
Figure 41. Americas Nicotinamide Mononucleotide (NMN) Revenue 2021-2026 ($ millions)
Figure 42. APAC Nicotinamide Mononucleotide (NMN) Sales 2021-2026 (Tons)
Figure 43. APAC Nicotinamide Mononucleotide (NMN) Revenue 2021-2026 ($ millions)
Figure 44. Europe Nicotinamide Mononucleotide (NMN) Sales 2021-2026 (Tons)
Figure 45. Europe Nicotinamide Mononucleotide (NMN) Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales 2021-2026 (Tons)
Figure 47. Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue 2021-2026 ($ millions)
Figure 48. Americas Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2025
Figure 49. Americas Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2021-2026)
Figure 50. Americas Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2021-2026)
Figure 51. Americas Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2021-2026)
Figure 52. United States Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC Nicotinamide Mononucleotide (NMN) Sales Market Share by Region in 2025
Figure 57. APAC Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2021-2026)
Figure 58. APAC Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2021-2026)
Figure 59. APAC Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2021-2026)
Figure 60. China Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 64. India Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2025
Figure 68. Europe Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2021-2026)
Figure 69. Europe Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2021-2026)
Figure 70. Europe Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2021-2026)
Figure 71. Germany Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 72. France Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 73. UK Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2021-2026)
Figure 79. Egypt Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Nicotinamide Mononucleotide (NMN) in 2026
Figure 85. Manufacturing Process Analysis of Nicotinamide Mononucleotide (NMN)
Figure 86. Industry Chain Structure of Nicotinamide Mononucleotide (NMN)
Figure 87. Channels of Distribution
Figure 88. Global Nicotinamide Mononucleotide (NMN) Sales Market Forecast by Region (2027-2032)
Figure 89. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Nicotinamide Mononucleotide (NMN)
Figure 2. Nicotinamide Mononucleotide (NMN) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nicotinamide Mononucleotide (NMN) Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Nicotinamide Mononucleotide (NMN) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Nicotinamide Mononucleotide (NMN) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2025)
Figure 10. Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Content ?98%
Figure 12. Product Picture of Content ?98%
Figure 13. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Type in 2026
Figure 14. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Enzymatic Catalysis
Figure 16. Product Picture of Microbial Fermentation
Figure 17. Product Picture of Chemical Synthesis
Figure 18. Product Picture of Other
Figure 19. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Production Process in 2026
Figure 20. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Production Process (2021-2026)
Figure 21. Product Picture of Food Grade
Figure 22. Product Picture of Cosmetic Grade
Figure 23. Product Picture of Pharmaceutical Grade
Figure 24. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Grade in 2026
Figure 25. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Grade (2021-2026)
Figure 26. Nicotinamide Mononucleotide (NMN) Consumed in Health Care Products
Figure 27. Global Nicotinamide Mononucleotide (NMN) Market: Health Care Products (2021-2026) & (Tons)
Figure 28. Nicotinamide Mononucleotide (NMN) Consumed in Cosmetics
Figure 29. Global Nicotinamide Mononucleotide (NMN) Market: Cosmetics (2021-2026) & (Tons)
Figure 30. Nicotinamide Mononucleotide (NMN) Consumed in Others
Figure 31. Global Nicotinamide Mononucleotide (NMN) Market: Others (2021-2026) & (Tons)
Figure 32. Global Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2025)
Figure 33. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application in 2025
Figure 34. Nicotinamide Mononucleotide (NMN) Sales by Company in 2025 (Tons)
Figure 35. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Company in 2025
Figure 36. Nicotinamide Mononucleotide (NMN) Revenue by Company in 2025 ($ millions)
Figure 37. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company in 2025
Figure 38. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Nicotinamide Mononucleotide (NMN) Sales 2021-2026 (Tons)
Figure 41. Americas Nicotinamide Mononucleotide (NMN) Revenue 2021-2026 ($ millions)
Figure 42. APAC Nicotinamide Mononucleotide (NMN) Sales 2021-2026 (Tons)
Figure 43. APAC Nicotinamide Mononucleotide (NMN) Revenue 2021-2026 ($ millions)
Figure 44. Europe Nicotinamide Mononucleotide (NMN) Sales 2021-2026 (Tons)
Figure 45. Europe Nicotinamide Mononucleotide (NMN) Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales 2021-2026 (Tons)
Figure 47. Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue 2021-2026 ($ millions)
Figure 48. Americas Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2025
Figure 49. Americas Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2021-2026)
Figure 50. Americas Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2021-2026)
Figure 51. Americas Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2021-2026)
Figure 52. United States Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC Nicotinamide Mononucleotide (NMN) Sales Market Share by Region in 2025
Figure 57. APAC Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2021-2026)
Figure 58. APAC Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2021-2026)
Figure 59. APAC Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2021-2026)
Figure 60. China Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 64. India Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2025
Figure 68. Europe Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2021-2026)
Figure 69. Europe Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2021-2026)
Figure 70. Europe Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2021-2026)
Figure 71. Germany Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 72. France Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 73. UK Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2021-2026)
Figure 79. Egypt Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries Nicotinamide Mononucleotide (NMN) Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Nicotinamide Mononucleotide (NMN) in 2026
Figure 85. Manufacturing Process Analysis of Nicotinamide Mononucleotide (NMN)
Figure 86. Industry Chain Structure of Nicotinamide Mononucleotide (NMN)
Figure 87. Channels of Distribution
Figure 88. Global Nicotinamide Mononucleotide (NMN) Sales Market Forecast by Region (2027-2032)
Figure 89. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Application (2027-2032)
More Publications
Global Waterproofing Chemicals Market Growth 2025-2031
US$ 3,660.00
December 2025
91 pages
Global Unsaturated Polyester Molding Compounds Market Growth 2025-2031
US$ 3,660.00
September 2025
165 pages
